Biotech

Asian Activities Report for October 27, 2011: C @ Limited (ASX:CEO) To Acquire Eight Highly Prospective Mongolian Coal Licences

🕔10/27/2011 12:00:39 PM

Asian Activities Report for October 27, 2011 includes: C @ Limited (ASX:CEO) has signed an agreement to acquire eight highly prospective Mongolian coal licences for US$7.8 millions; African Iron Limited (ASX:AKI) announces a 267% increase in the JORC hematite mineral resource to 121 million tonnes at its 92% owned Mayoko Iron Ore Project in Congo; ENK Plc (ASX:ENK) announces the first nickel production from its pilot plant located 250 km north of Manila in the Philippines; Solagran Limited (ASX:SLA) recently visited an Asian country where a poultry trial was conducted in collaboration with a government body in the field of poultry production and disease management.

Read Full Article

Mesoblast Limited (ASX:MSB) Cleared to Begin First Phase 2 Clinical Trial for Eye Diseases

🕔10/24/2011 9:48:42 AM

Regenerative medicine company Mesoblast Limited (ASX:MSB) (PINK:MBLTY) today announced that it has received regulatory clearance from the Singapore Health Sciences Authority (HSA) to commence the first Phase 2 trial of its proprietary allogeneic (off-the-shelf) adult stem cell therapy for patients with proliferation of leaky blood vessels in the eyes - neovascular ("wet") Age-related Macular Degeneration (AMD). Wet AMD causes sudden and severe central vision loss and accounts for approximately 90 percent of all blindness in the elderly. Mesoblast is developing a stem cell therapeutic product for treating various vascular diseases of the eye, including wet AMD and diabetic macular edema (DME).

Read Full Article

Mesoblast Limited (ASX:MSB) Received Licensing Executives Society 2011 Deals of Distinction(TM) Award

🕔10/20/2011 10:21:00 AM

Mesoblast Limited (ASX:MSB) and its strategic alliance partner Cephalon Inc. were today awarded the Licensing Executives Society (U.S.A. and Canada), Inc. 2011 Deals of Distinction(TM) Award. The award was conferred for the most compelling licensing and intellectual property-related deal in the life sciences sector.

Read Full Article

Asian Activities Report for October 18, 2011: Algae. Tec Limited (ASX:AEB) to Build Algae Demonstration Plant in Sydney for Alternative Fuel Solutions

🕔10/18/2011 1:03:52 PM

Asian Activities Report for October 18, 2011 includes: Algae. Tec Limited (ASX:AEB) has received regulatory approvals for the development of an algae demonstration plant in the south of Sydney; Helicon Group Limited (ASX:HCG) today announces the execution of a definitive agreement to acquire Aspen Medisys; Alkane Resources Limited (ASX:ALK) has signed an agreement with the NSW Government to receive financial assistance for the infrastructure development of the Tomingley Gold Project in the Central West of NSW; Transerv Energy Limited (ASX:TSV) has completed the initial 10-day test of the Upper Zone at the Warro-4 onshore well in Western Australia; Augur Resources Limited (ASX:AUK) reports extensive gold and copper results from the Randu Kuning prospect, Wonogiri project in Central Java.

Read Full Article

Asian Activities Report for October 17, 2011: International Coal Limited (ASX:ICX) Expands Coal Drilling Programme at South Blackall Project

🕔10/17/2011 12:00:23 PM

Asian Activities Report for October 17, 2011 includes: International Coal Limited (ASX:ICX) has expanded the drilling programme at its wholly owned South Blackall Project in Queensland; Avanco Resources Limited (ASX:AVB) reported excellent results from the Rio Verde Copper Project in Brazil; Cardia Bioplastics Limited (ASX:CNN) has received BioNexus Status in Malaysia; Mantle Mining Corporation Limited (ASX:MNM) has completed the first 4 holes of a 15 hole drill program at the Company's 100% owned Bacchus Marsh coal project in Victoria; Vocus Communications (ASX:VOC), a Seven Group Holdings (ASX:SVW) company, has secured a multi-year deal to provide IP Transit and Data Centre services to leading 4G wireless provider vividwireless.

Read Full Article

Agenix Limited (ASX:AGX) Signed New China Agreements to Advance Lead Drug Candidate and New Product Pipeline

🕔10/13/2011 8:26:00 AM

Agenix Limited (ASX:AGX) today confirmed it had signed two new agreements with its strategic partners in China covering the commercialisation of new drug candidates, the sharing of resources, expertise and completion of pre-clinical toxicology tests for its new hepatitis B drug in China.

Read Full Article

Asian Activities Report for October 10, 2011: Carabella Resources (ASX:CLR) Appoints New Managing Director to Strengthen Expertise in the Coal Industry

🕔10/10/2011 12:00:44 PM

Asian Activities Report for October 10, 2011 includes: Carabella Resources Limited (ASX:CLR) announced the appointment of experienced coal industry executive Anthony Quin as Managing Director; Tasman Resources Limited (ASX:TAS) has signed a conditional agreement with Rio Tinto Limited (ASX:RIO) for the funding of an accelerated exploration program on Tasman's Vulcan prospect; Acer Energy Limited (ASX:ACN) has executed a conditional Sale and Purchase Agreement with Sundance Energy Australia Limited (ASX:SEA) to acquire all of Sundance's 23.33% working interest in Petroleum Exploration Licence 100; Starpharma Holdings Limited (ASX:SPL) has received agreement from the US Food and Drug Administration regarding the Phase 3 clinical trial program for the Company's VivaGel (R) bacterial vaginosis treatment.

Read Full Article